NYSE American - Delayed Quote USD

BiomX Inc. (PHGE)

0.5160
-0.0411
(-7.38%)
At close: May 9 at 4:00:00 PM EDT
0.5212
+0.01
+(1.01%)
After hours: May 9 at 6:27:14 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
35,551
35,551
25,348
27,219
35,462
Operating Income
-35,551
-35,551
-25,348
-27,219
-35,462
Net Non Operating Interest Income Expense
-1,738
-1,738
-1,338
-1,618
-620
Other Income Expense
19,575
19,575
540
585
-77
Pretax Income
-17,714
-17,714
-26,146
-28,252
-36,159
Tax Provision
13
13
23
65
67
Net Income Common Stockholders
-17,727
-17,727
-26,169
-28,317
-36,226
Average Dilution Earnings
-26,458
-26,458
0
--
--
Diluted NI Available to Com Stockholders
-44,185
-44,185
-26,169
-28,317
-36,226
Basic EPS
-1.47
-1.47
-5.10
-9.50
-13.90
Diluted EPS
-1.47
-1.47
-5.10
-9.50
-13.90
Basic Average Shares
12,019.4010
12,019.4010
5,133.0320
2,985.4000
2,600.7940
Diluted Average Shares
13,138.1060
13,138.1060
5,133.0320
2,985.4000
2,600.7940
Total Operating Income as Reported
-44,523
-44,523
-25,348
-27,219
-35,462
Rent Expense Supplemental
593
593
298
346
291
Total Expenses
35,551
35,551
25,348
27,219
35,462
Net Income from Continuing & Discontinued Operation
-17,727
-17,727
-26,169
-28,317
-36,226
Normalized Income
-31,149.6400
-31,149.6400
-26,309.9100
-28,664.2700
-36,166.7100
Interest Income
1,048
1,048
1,122
464
86
Interest Expense
873
873
2,404
2,069
699
Net Interest Income
-1,738
-1,738
-1,338
-1,618
-620
EBIT
-16,841
-16,841
-23,742
-26,183
-35,460
EBITDA
-15,038
-15,038
-22,871
-23,663
-32,895
Reconciled Depreciation
1,803
1,803
871
2,520
2,565
Net Income from Continuing Operation Net Minority Interest
-17,727
-17,727
-26,169
-28,317
-36,226
Total Unusual Items Excluding Goodwill
17,432
17,432
183
451
-77
Total Unusual Items
17,432
17,432
183
451
-77
Normalized EBITDA
-32,470
-32,470
-23,054
-24,114
-32,818
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
4,009.3600
4,009.3600
42.0900
103.7300
-17.7100
12/31/2021 - 3/13/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ARMP Armata Pharmaceuticals, Inc.
1.2900
-5.15%
 
SPPH Spencer Pharmaceutical Inc.
0.0001
0.00%
 
LIANY LianBio
0.2000
+8.99%
 
APTOF Aptose Biosciences Inc.
1.6500
0.00%
 
INVA Innoviva, Inc.
18.56
-0.11%
 
CLRPF Clarity Pharmaceuticals Ltd
1.5500
0.00%
 
CLGN CollPlant Biotechnologies Ltd.
1.8200
-0.55%
 
EVGN Evogene Ltd.
1.1325
+0.22%
 
NAVB Navidea Biopharmaceuticals, Inc.
0.0006
0.00%
 
MTEM Molecular Templates, Inc.
0.0001
0.00%